Not available
Quote | Nektar Therapeutics (NASDAQ:NKTR)
Last: | $1.81 |
---|---|
Change Percent: | -1.09% |
Open: | $1.83 |
Close: | $1.83 |
High: | $1.83 |
Low: | $1.79 |
Volume: | 805,250 |
Last Trade Date Time: | 05/16/2024 03:00:00 am |
News | Nektar Therapeutics (NASDAQ:NKTR)
2024-05-09 22:40:25 ET Nektar Therapeutics, Inc. (NKTR) Q1 2024 Earnings Conference Call May 09, 2024, 17:00 ET Company Participants Vivian Wu - Associate Director, Investor Relations and Corporate Affairs Howard Robin - President, CEO & Director Jonathan Zal...
2024-05-09 16:22:16 ET More on Nektar Therapeutics Nektar Therapeutics Sees Something In The Data And Puts Its Drug To The Test Nektar Therapeutics (NKTR) Q4 2023 Earnings Call Transcript Nektar Therapeutics Q1 2024 Earnings Preview Seeking Alpha’s Qua...
Message Board Posts | Nektar Therapeutics (NASDAQ:NKTR)
Subject | By | Source | When |
---|---|---|---|
pincher chart on the daily and weekly, I | DavidTrader | investorshub | 03/27/2023 5:14:28 PM |
Hmmm just crickets around here, I dont mind | Lilman72003 | investorshub | 03/22/2023 8:17:33 PM |
whytestocks: $NKTR News Article - Nektar Therapeutics' President and CEO, Howard Robin, To Present a | whytestocks | investorshangout | 01/04/2023 5:25:56 PM |
whytestocks: $NKTR News Article - Nektar Therapeutics to Host Webcast Conference Call for Analysts & | whytestocks | investorshangout | 04/22/2022 6:55:51 PM |
NKTR -24%/AH on_termination_of Bempeg program following phase-3 failures | DewDiligence | investorshub | 04/14/2022 9:23:32 PM |
News, Short Squeeze, Breakout and More Instantly...
Nektar Therapeutics Reports First Quarter 2024 Financial Results PR Newswire SAN FRANCISCO , May 9, 2024 /PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR) today reported financial results for the first quarter ended March 31, 2024 . Cash and ...
Nektar to Announce Financial Results for the First Quarter 2024 on Thursday, May 9, 2024, After Close of U.S.-Based Financial Markets PR Newswire SAN FRANCISCO , May 2, 2024 /PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR) will announce its financial results fo...
Nektar Management to Present at the H.C. Wainwright 2nd Annual Autoimmune & Inflammatory Disease Virtual Conference Nektar Management to Present at the H.C. Wainwright 2nd Annual Autoimmune & Inflammatory Disease Virtual Conference PR Newswire SAN FRANCISCO ,...